Quarterly report pursuant to Section 13 or 15(d)

Accrued expenses and other current liabilities

v3.23.3
Accrued expenses and other current liabilities
9 Months Ended
Sep. 30, 2023
Accrued expenses and other current liabilities  
Accrued expenses and other current liabilities

Note 10 Accrued expenses and other current liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

September 30, 

December 31, 

    

2023

    

2022

Accrued clinical and development expenditure

$

13,208

$

16,749

Accrued employee expenses

11,047

8,232

Other accrued expenditure

2,504

4,079

Other

 

72

 

2,155

$

26,831

$

31,215